Clinical Factors Associated With Treatment Noncompliance in Euthymic Bipolar Patients
J Clin Psychiatry 2000;61:549-555
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Noncompliance with medication is a
very common feature among bipolar patients. Rates of poor
compliance may reach 64% for bipolar disorders, and noncompliance
is the most frequent cause of recurrence. Knowledge of the
clinical factors associated with noncompliance would enhance
clinical management and the design of strategies to achieve a
better outcome for bipolar patients. Although most patients
withdraw from medication during maintenance treatment, compliance
studies in euthymic bipolar samples are scarce.
Method: Compliance treatment and its clinical
correlates were assessed at the end of 2-year follow-up in 200
patients meeting Research Diagnostic Criteria for bipolar I or
bipolar II disorder by means of compliance-focused interviews,
measurements of plasma concentrations of mood stabilizers, and 2
structured interviews: the Schedule for Affective Disorders and
Schizophrenia and the Structured Clinical Interview for DSM-III-R
Axis II disorders. Well-compliant patients and poorly compliant
patients were compared with respect to several clinical and
Results: The rate of mildly and poorly compliant
patients was close to 40%. Comorbidity with personality disorders
was strongly associated with poor compliance. Poorly compliant
patients had a higher number of previous hospitalizations, but
reported fewer previous episodes. The type of treatment was not
associated with compliance.
Conclusion: Clinical factors, especially
comorbidity with personality disorders, are more relevant for
treatment compliance than other issues such as the nature of
pharmacologic treatment. Compliant patients may have a better
outcome in terms of number of hospitalizations, but not necessarily with respect to the number of episodes. Bipolar
patients, especially those with personality disorders, should be
monitored for treatment compliance.